Skip to content

Post-herniotomy pain relief: caudal block versus a combination of intravenous ketorolac and paracetamol

COMPARISON OF PREINCISIONAL CAUDAL BLOCK AND A COMBINATION OF INTRAVENOUS KETOROLAC AND PARACETAMOL FOR POST-HERNIOTOMY PAIN RELIEF

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202508818107780
Enrollment
88
Registered
2025-08-14
Start date
2021-04-12
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

Intravenous Ketorolac plus Paracetamol

Sponsors

Ifeanyichukwu Michael Chukwu
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: • ASA I or II patients • Age 1 to 8 years • Elective unilateral herniotomy

Exclusion criteria

Exclusion criteria: • Parent’s or guardian’s refusal. • Body weight > 25kg. • Septic spots over sacral region. • Sacral bone deformity. • Day cases. • History of bleeding disorders. • Allergy to bupivacaine, ketorolac or paracetamol. • Patients with hepatic or renal disease. • Presence of anal abnormalities. • Co-existing neurological diseases. • Peptic ulcer disease. • Bilateral herniotomy. • History of asthma

Design outcomes

Primary

MeasureTime frame
The proportion of patients scoring either = 5 points (pain-free) if self-reporting or = 4 points (pain-free) if not self-reporting using the Objective Pain Scale at each pain assessment interval will form the primary outcome measure.

Secondary

MeasureTime frame
Time to first analgesic requirement postoperatively. ;Mean analgesic consumption in 24 hours postoperatively (in milligrams);Frequency of Pentazocine dosing in 24 hours postoperatively;Changes in baseline and intraoperative pulse rate, blood pressure, respiratory rate and oxygen saturation (SpO2).;Incidence of complications associated with the use of caudal bupivacaine or intravenous ketorolac and paracetamol such as hypotension, urinary retention, leg weakness and vomiting.;Parental satisfaction of analgesic comfort of the children.

Countries

Nigeria

Contacts

Public ContactJulian Ojebo

Consultant Anaesthetist and Head of Department of Anaesthesia Garki Hospital Abuja

ojebojulian@gmail.com+2349020284145

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026